RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NAVB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Navidea Biopharmaceuticals Inc stock price on Thursday which ended trading at $0.0365
(Updated on Mar 28, 2024)

Sell candidate since Mar 26, 2024 Gain 1.11% PDF

The Navidea Biopharmaceuticals Inc stock price gained 2.82% on the last trading day (Thursday, 28th Mar 2024), rising from $0.0355 to $0.0365. During the last trading day the stock fluctuated 25.24% from a day low at $0.0330 to a day high of $0.0413. The price has fallen in 5 of the last 10 days and is down by -18.53% for this period. Volume fell on the last day by -57 thousand shares and in total, 64 thousand shares were bought and sold for approximately $2.34 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -31.16% during the next 3 months and, with a 90% probability hold a price between $0.0159 and $0.0329 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NAVB Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, March 27, 2024, and so far it has risen 2.82%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Navidea Biopharmaceuticals Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $0.0407 and $0.0403. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Sell
Special Signal Notification

Double Top Formation

Double Top Formation A sell signal from a double top formation was found on Wednesday, March 20, 2024 and based on theory for this formation the price should fall by -24.75% to $0.0275 within 21 trading days since signal was issued (Monday, April 01, 2024).

Support, Risk & Stop-loss for Navidea Biopharmaceuticals Inc stock

Navidea Biopharmaceuticals Inc finds support from accumulated volume at $0.0360 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0083 between high and low, or 25.24%. For the last week the stock has had daily average volatility of 18.52%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NAVB) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Navidea Biopharmaceuticals Inc to open at $0.0369, and during the day (based on 14 day Average True Range), to move between $0.0279 and $0.0451, which gives a possible trading interval of +/-$0.0086 (+/-23.65%) up or down from last closing price. If Navidea Biopharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 47.30% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0360 (1.37%) than the resistance at $0.0371 (1.64%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Navidea Biopharmaceuticals Inc stock A Buy?

Navidea Biopharmaceuticals Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -2.671 Sell Candidate Upgraded

Predicted Opening Price for Navidea Biopharmaceuticals Inc of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$0.0369 ( 1.21%) $0.0365

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NAVB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0453 24.04 %
R2 0.0421 15.32 %
R1 0.0401 9.93 %
Current price: 0.0365
Support S1 0.0338 -7.50 %
S2 0.0318 -12.89 %
S3 0.0286 -21.61 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0406 11.23 %
R2 0.0380 4.11 %
R1 0.0371 1.64 %
Current price 0.0365
Support S1 0.0360 -1.37%
S2 0.0350 -4.11%
S3 0.0345 -5.48%

FAQ

What is the symbol for Navidea Biopharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Navidea Biopharmaceuticals Inc is NAVB and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Navidea Biopharmaceuticals Inc Stock?
Navidea Biopharmaceuticals Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Navidea Biopharmaceuticals Inc Stock?
Navidea Biopharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Navidea Biopharmaceuticals Inc Stock.

What's the current price of Navidea Biopharmaceuticals Inc Stock?
As of the end of day on the 2024-03-28, the price of an Navidea Biopharmaceuticals Inc (NAVB) share was $0.0365.

What is the 52-week high and low for Navidea Biopharmaceuticals Inc Stock?
The 52-week high for Navidea Biopharmaceuticals Inc Stock is $0.330 and the 52-week low is $0.0210.

What is the market capitalization of Navidea Biopharmaceuticals Inc Stock?
As of the 2024-03-28, the market capitalization of Navidea Biopharmaceuticals Inc is 3.653M.

When is the next earnings date for Navidea Biopharmaceuticals Inc ?
The upcoming earnings date for Navidea Biopharmaceuticals Inc is May 09, 2024.
Click to get the best stock tips daily for free!

About Navidea Biopharmaceuticals Inc

Navidea Biopharmaceuticals Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages for a range of diagnostic modalities, including single photon emission c... NAVB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT